Can selenium supplementation help children undergoing cancer treatment?
We need more clinical studies of the topic. However, here is what we know:
Selenium supplements may help to modulate inflammatory responses in pediatric oncology patients.
Children in chemotherapy often have low serum selenium status. The reasons include low dietary selenium intake, increased oxidative stress, and altered metabolism [Podpeskar 2023].
Optimal selenium intake is important. Antioxidant enzymes such as the glutathione peroxidases and selenoprotein P incorporate selenium. In the body, these antioxidant enzymes help protect cells from oxidative damage [Podpeskar 2023].
Selenium supplementation can alter the gene expression of antioxidant and inflammatory regulators in children with cancer. This suggests evidence of molecular activity even if the levels of inflammatory markers in the blood remain unchanged [Delgado 2026].
How can selenium supplements complement cancer treatment in children?
Delgado et al investigated the extent to which selenium supplementation can modulate antioxidant defense mechanisms and inflammation in children and adolescents undergoing treatment for cancer. The researchers knew that children need selenium to regulate immune function and oxidative stress.read more
What is still a major problem in breast cancer therapy?
In preclinical studies, selenium compounds show promising efficacy against drug-resistant breast cancer.
Over time, many breast tumors become resistant to chemotherapy. Thus, drug-resistant tumors limit the success of anti-cancer therapies. Numerous mechanisms decrease the intracellular accumulation of anti-cancer drugs. In this way, breast cancer tumors become less responsive to the chemotherapy [Baier 2026].
Does supplementary selenium have anti-cancer properties?
Selenium is an essential trace element. Through the activity of selenoproteins, selenium is involved in the following potentially anti-cancer activities [Baier 2026]:
Antioxidant defense
Immune modulation
Redox regulation
Note: Cancer cells often rely on altered redox balance. Accordingly, selenium compounds may disrupt tumor survival mechanisms. At the same time, they can spare normal cells and tissues.
How do selenium compounds attack drug-resistant Breast cancer cells?
In a 2026 review, Baier et al make the point that multi-drug resistance in breast cancer often stems from several resistance pathways acting together. Thus, selenium-containing compounds may help overcome breast cancer patients’ multi-drug resistance via overlapping multiple mechanisms:read more
Cancer treatment. What do we know at the present time about the effectiveness of selenium as an adjuvant treatment in cancer patients? In a 2024 systematic review, researchers have evaluated the existing evidence from data from 12 studies with 2,483 adult patients undergoing cancer treatment. The types of cancer included non-Hodgkin lymphoma, head and neck cancer, thyroid cancer, acute myeloid or acute lymphocytic leukemia, stage I non-small lung cancer, breast cancer, cervical and endometrial cancer, prostate cancer, and non-invasive urothelial carcinoma [Krannich 2024].
More information is needed about the effects of adjuvant treatment of cancer patients with selenium supplements. Similarly, more information is needed about the concurrent use of selenium supplements in patients receiving chemotherapy and radiation therapy.
The researchers’ analysis of the available data does not give a clear picture of the efficacy of selenium administration to adult cancer patients. One reason is that several of the evaluated studies did not report measurements of the patients’ serum selenium levels at the beginning or the end of the study. The studies that did report serum selenium levels used different ways to measure selenium levels. Moreover, the duration of the selenium administration and the type of selenium preparation and the dosage varied from study to study [Krannich 2024].read more
Selenium deficiency, especially as manifested in low circulating levels of selenoprotein P, is associated significantly with an increased risk of colorectal cancer incidence and mortality [Pal 2024; Brezina 2025]. SELENOP is a selenium-dependent glycoprotein that is the primary transporter of selenium to the tissues and organs. SELENOP also acts to reduce oxidative stress and systemic inflammation [Schöttker 2024; Brezina 2025].
Colorectal cancer risk is elevated in selenium and SELENOP deficiency. Serum SELENOP concentration is perhaps the single most useful parameter for prognosis once the diagnosis has been made. SELENOP concentrations below 2.5 mg/L indicate severe deficiency. Concentrations below 5.0 mg/L suggest elevated risk.
In the Colorectal Cancer Study of Austria (CORSA Study), researchers analyzed data from 519 participants (n = 153 tumor-free controls, n = 255 patients with adenomas, and n = 111 patients with colorectal cancer). The median age of the study participants was 65 years. Nearly two-thirds of the study participants were male. The study participants’ median plasma selenium concentration was a very low 65.7 mcg/L. Their median SELENOP concentration was also low: 2.7 mg/L. During a median follow-up period of 5,424 days (almost 15 years), there were 210 deaths (40 %) [Brezina 2025].read more
Adult cancer patients who have a selenium deficiency can benefit from selenium supplementation during their radiotherapy and/or chemotherapy. This is the conclusion from a 2024 systematic review. The researchers examined the pooled data from 12 clinical studies enrolling 2,483 patients. The reviewed studies investigated the use of selenium substitution therapy in adult cancer patients undergoing cancer treatment [Krannich 2024].
A review of 15 years of selenium supplementation has shown promising results in radiation therapy in tumor patients with a relative selenium deficit.
The researchers defined selenium deficiency as serum or plasma selenium concentrations below 80 mcg/L or as whole blood selenium concentrations below 100 mcg/L. Furthermore, they regarded serum or plasma selenium levels over 130 mcg/L as replete status [Krannich 2024].read more
The evidence for the use of selenium supplementation in cancer prevention is still inconclusive. Rataan et al suggest that the fault may lie in the design of the existing studies. At least two factors have contributed to this lack of conclusive evidence:
the use of different compounds in the tests of selenium and cancer
the different blood selenium levels of the study participants at baseline
Selenium supplementation of individuals with low dietary intakes of selenium may help prevent the development of certain types of cancer.
As an example, Rataan et al cite the differences between the Nutritional Prevention of Cancer (NPC) trial and the Selenium and Vitamin E Cancer Prevention Trial (SELECT). In the NPC study, the researchers used a selenium-enriched yeast supplement. This yeast formulation contained mostly selenomethionine but also contained several other selenium species including Se-methylselenocysteine. In the SELECT study, the researchers used a 100% selenomethionine supplement. It now seems clear that the chemopreventive effect of selenium that was seen in the NPC study but not seen in the SELECT study must have come from some selenium species other than selenomethionine. The most likely chemopreventive selenium species is the Se-methylselenocysteine [Rataan 2022; Marshall 2017].read more
Reduced risk of heart disease and reduced risk of some cancers. Increasing the daily intake of selenium among individuals with low selenium status may reduce the risk of cardiovascular disease and some cancers. The available data seem to show that most adults in the Nordic and Baltic countries, with the exception of adults in Finland, have low selenium intakes and low selenium status [Alexander & Olsen 2023].
Prof. Jan Alexander, MD, PhD, Norwegian Institute of Public Health in Oslo, says: There are various factors that influence cardiovascular disease mortality and cancer incidence: diet, lifestyle, genetics, inter alia. The impact of these factors varies from one Nordic country to the next.
Selenium is an essential trace element. The human body cannot synthesize it. It must come from the diet and supplements. Selenium is a vital component of selenoproteins that are critical to normal health and physiological functioning. This is the fundamental message from a 2023 selenium scoping review conducted for the Nordic Nutritional Recommendations 2023 [Alexander & Olsen 2023].read more
Cancer patients tend to have reduced serum selenium concentrations compared to healthy controls. Adjuvant selenium supplementation improves the protection of healthy tissue in tumor patients undergoing radiation therapy [Muecke 2018].
15 years of experience with adjuvant selenium supplementation in radiation oncology in Germany has yielded a solid knowledge database. As a result, some radiation oncologists measure the patient’s selenium levels during therapy and compensate in cases of selenium deficiency. Even so, it is important to remember that selenium status is a relatively small piece in the bigger puzzle of therapeutic success in radiation oncology.
In a 2018 review of 15-years of experience with selenium supplementation in radiation oncology, Muecke et al [2018] reported on two randomized controlled trials. The researchers observed positive effects of the supplemental selenium and no adverse effects in the patients undergoing radiation therapy:
81 patients with uterine cancer
39 patients with head and neck tumors
Selenium Deficit in Cancer Patients
In the majority of the tumor patients (carcinomas of the uterus, head and neck, lungs, rectum or prostate) whom they examined, German researchers found a relative selenium deficit in whole blood or serum [Muecke 2018].read more
Selenium yeast supplementation administered concurrently with chemotherapy and radiation therapy effectively increased blood selenium levels in cervical cancer patients with inadequate selenium status. The selenium yeast supplementation was used as an adjuvant treatment to the standard chemotherapy and radiation therapy. It significantly decreased the hematologic toxicity of the chemoradiotherapy [Yang 2023].
Each year, worldwide, half a million women are diagnosed with cervical cancer, and 300 000 die from the disease. In most cases, the human papilloma virus is the cause of the disease [Cohen 2019]. The trace element selenium has antiviral properties. Cell studies and mouse studies of cervical cancer have shown that different selenium species have anticancer effects in cervical cancer induced by human papilloma virus or by chemical carcinogens [Jablonska 2021].In a randomized controlled trial, researchers randomly assigned 104 patients diagnosed with stage IIB cervical cancer receive 100 mcg selenium yeast tablets (n=50) or matching placebos twice daily (n=54) for five weeks [Yang 2023].
All patients in both groups received the standard treatment including pelvic external irradiation, concurrent five cycles of chemotherapy, and brachytherapy [Yang 2023].read more
Breast cancer prognosis is especially poor in patients with low serum selenium and serum selenoprotein P concentrations. Now, researchers have discovered natural autoantibodies with antagonistic properties to selenoprotein P uptake in breast cancer patients and in patients with thyroid disease [Demircan 2022; Sun 2022].
Autoimmunity is the production of antibodies against the tissues or substances of one’s own body, resulting in an autoimmune disease or hypersensitivity reaction. Autoantibodies to Selenoprotein P impair the transport of the essential trace element selenium in breast cancer patients and in Hashimoto’s thyroiditis patients.
Selenium is an essential trace element that has numerous biological functions in the body, most of which are carried out by selenium-containing selenoproteins. Among the more important selenoproteins are selenoprotein P, the main transporter of selenium in the blood, and glutathione peroxidase 3 (GPX3), an important antioxidant.
The human body does not synthesize selenium. Human cells are dependent upon selenium sources in the diet. Unfortunately, the selenium content in the soil and in food varies considerably from region to region in the world. For example, the plasma selenium concentrations in people living in much of Europe are generally below, often well below, 80–90 mcg/L whereas people living in North America generally have plasma selenium levels above 120 mcg/L [Alehagen 2022].read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
